+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Molecular Disease Treatments in Molecular Pathology · Registering as Listener

ICMDTMP
📅 17 – 18 Mar 2027 📍 New Taipei City, Taiwan 👥 Standard / Physical Participation
Listener Registration From
$165
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Molecular Disease Treatments in Molecular Pathology
ModeStandard / Physical
ParticipationListener
Registration fee$165.00
Bank charges (5.8%)$9.57
Total payable $174.57

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 6 SDG 9

This track will explore the underlying molecular mechanisms that contribute to various pathological conditions. Emphasis will be placed on the role of genetic and epigenetic factors in disease development and progression.

This session will focus on cutting-edge molecular testing and histopathological techniques in the diagnosis of skin diseases. Participants will discuss the implications of these advancements for clinical practice and patient outcomes.

This track will examine the epidemiological trends and molecular characteristics of infectious diseases, including molluscum contagiosum. Discussions will highlight the importance of understanding these factors for effective public health strategies.

This session will address the challenges in diagnosing and managing neoplastic diseases, with a focus on Merkel cell carcinoma and lymphomas. The integration of molecular diagnostics into clinical decision-making will be a key theme.

This track will delve into the role of immunophenotyping in the diagnosis and classification of hematological malignancies. Participants will share insights on how these techniques enhance our understanding of disease mechanisms.

This session will explore the latest findings in the molecular pathology of various cancers, including mechanisms of tumorigenesis and progression. The focus will be on how these insights can inform therapeutic strategies.

This track will discuss innovative therapeutic approaches informed by molecular pathology, including targeted therapies and personalized medicine. Participants will evaluate the efficacy and safety of these treatments in clinical settings.

This session will highlight the advancements in molecular diagnostics and their application in therapeutic interventions. Discussions will include case studies demonstrating the impact of these technologies on patient care.

This track will focus on the role of dermatopathology in forensic autopsy cases, emphasizing the importance of accurate diagnosis in legal contexts. Participants will discuss methodologies and case studies that illustrate these applications.

This session will explore integrated approaches to disease management that combine molecular diagnostics with clinical practice. The goal is to enhance patient outcomes through a multidisciplinary approach.

This track will examine emerging trends and technologies in molecular genetic pathology, including their implications for disease diagnosis and treatment. Participants will discuss future directions and challenges in the field.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED